Rapid and Efficient Purification of Functional Collectin-12 and Its Opsonic Activity against Fungal Pathogens.


Journal

Journal of immunology research
ISSN: 2314-7156
Titre abrégé: J Immunol Res
Pays: Egypt
ID NLM: 101627166

Informations de publication

Date de publication:
2019
Historique:
received: 05 03 2019
accepted: 21 06 2019
entrez: 5 9 2019
pubmed: 5 9 2019
medline: 25 1 2020
Statut: epublish

Résumé

Collectin-12 (collectin placenta 1, CL-P1, or CL-12) is a newly identified pattern recognition molecule of the innate immune system. Recent evidences show that CL-12 plays important roles not only in innate immune protection against certain clinically important pathogens but also in scavenging of host molecules, leukocyte recruitment, and cancer metastasis. Furthermore, CL-12 has been shown to be associated with the pathogenesis of human diseases such as Alzheimer's disease and multiple sclerosis lesion development. Therefore, the functional consequence of CL-12 remains intriguing and awaits further elucidation. However, available protocols for the purification of recombinant CL-12 with high purity are laborious and inefficient and hamper further functional studies. Here, we report a simple, rapid, and efficient solution to obtain biologically active CL-12 with high purity. We established stable transfected Flp-In™-CHO cells expressing the recombinant CL-12 extracellular domain in high amounts. Recombinant CL-12 was purified from cell culture supernatants using a 3-step rapid purification procedure utilizing disposable affinity and ion exchange minicolumns. Purified recombinant CL-12 adopted an oligomeric structure with monomers, dimers, and trimers and retained its binding capacity towards the

Identifiants

pubmed: 31482100
doi: 10.1155/2019/9164202
pmc: PMC6701420
doi:

Substances chimiques

COLEC12 protein, human 0
Collectins 0
Opsonin Proteins 0
Receptors, Scavenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9164202

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Biochem Biophys Res Commun. 2001 Feb 2;280(4):1028-35
pubmed: 11162630
J Biol Chem. 2001 Nov 23;276(47):44222-8
pubmed: 11564734
J Biochem. 2003 Mar;133(3):271-7
pubmed: 12761161
J Biol Chem. 2005 Jun 17;280(24):22993-9
pubmed: 15845541
Breast Cancer Res Treat. 2007 Jan;101(2):161-74
pubmed: 16850248
J Neurosci Res. 2006 Sep;84(4):874-90
pubmed: 16868960
J Biol Chem. 2007 Jun 8;282(23):17250-8
pubmed: 17420244
Mol Immunol. 2008 Jun;45(11):3278-88
pubmed: 18423602
Mycoses. 2008 Nov;51(6):477-96
pubmed: 18705662
J Biol Chem. 2009 Oct 9;284(41):28263-75
pubmed: 19632990
J Biol Chem. 2011 Feb 4;286(5):3405-17
pubmed: 21106539
J Immunol. 2013 Aug 1;191(3):1324-33
pubmed: 23817411
Biochim Biophys Acta. 2014 Dec;1840(12):3345-56
pubmed: 25199873
J Immunol. 2015 Oct 1;195(7):3365-73
pubmed: 26290605
Scand J Immunol. 2016 Jul;84(1):12-9
pubmed: 27104295
Immunobiology. 2016 Oct;221(10):1058-67
pubmed: 27377710
Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):1-14
pubmed: 27864148
Sci Rep. 2017 Mar 20;7:44794
pubmed: 28317919
Sci Rep. 2018 Feb 28;8(1):3821
pubmed: 29491476
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Clin Infect Dis. 1998 Apr;26(4):781-803; quiz 804-5
pubmed: 9564455

Auteurs

Jie Zhang (J)

The Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Ole Maaloesvej 26, 2200 Copenhagen N, Denmark.
Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 211198 Nanjing, China.

Anna Li (A)

The Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Ole Maaloesvej 26, 2200 Copenhagen N, Denmark.
Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 211198 Nanjing, China.

Chang-Qing Yang (CQ)

Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 211198 Nanjing, China.

Peter Garred (P)

The Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Ole Maaloesvej 26, 2200 Copenhagen N, Denmark.

Ying Jie Ma (YJ)

The Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Ole Maaloesvej 26, 2200 Copenhagen N, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH